Go to JCI Insight
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
  • Clinical Research and Public Health
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Gastroenterology
    • Immunology
    • Metabolism
    • Nephrology
    • Neuroscience
    • Oncology
    • Pulmonology
    • Vascular biology
    • All ...
  • Videos
    • Conversations with Giants in Medicine
    • Video Abstracts
  • Reviews
    • View all reviews ...
    • Pancreatic Cancer (Jul 2025)
    • Complement Biology and Therapeutics (May 2025)
    • Evolving insights into MASLD and MASH pathogenesis and treatment (Apr 2025)
    • Microbiome in Health and Disease (Feb 2025)
    • Substance Use Disorders (Oct 2024)
    • Clonal Hematopoiesis (Oct 2024)
    • Sex Differences in Medicine (Sep 2024)
    • View all review series ...
  • Viewpoint
  • Collections
    • In-Press Preview
    • Clinical Research and Public Health
    • Research Letters
    • Letters to the Editor
    • Editorials
    • Commentaries
    • Editor's notes
    • Reviews
    • Viewpoints
    • 100th anniversary
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • Reviews
  • Review series
  • Conversations with Giants in Medicine
  • Video Abstracts
  • In-Press Preview
  • Clinical Research and Public Health
  • Research Letters
  • Letters to the Editor
  • Editorials
  • Commentaries
  • Editor's notes
  • Reviews
  • Viewpoints
  • 100th anniversary
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
Autoantigen, innate immunity, and T cells cooperate to break B cell tolerance during bacterial infection
Pauline Soulas, … , Thierry Martin, Anne-Sophie Korganow
Pauline Soulas, … , Thierry Martin, Anne-Sophie Korganow
Published August 1, 2005
Citation Information: J Clin Invest. 2005;115(8):2257-2267. https://doi.org/10.1172/JCI24646.
View: Text | PDF
Research Article Immunology Article has an altmetric score of 3

Autoantigen, innate immunity, and T cells cooperate to break B cell tolerance during bacterial infection

  • Text
  • PDF
Abstract

Autoantibody production during infections is considered to result from nonspecific activation of low-affinity autoreactive B cells. Whether this can lead to autoimmune disease remains uncertain. We show that chronic infection by Borrelia burgdorferi of Tg animals expressing human rheumatoid factor (RF) B cells (of low or intermediate affinities) in the absence or in the constitutive presence of the autoantigen (represented here by chimeric IgG with human constant region) breaks their state of immunological ignorance, leading to the production of RFs. Surprisingly, this production was more pronounced in intermediate-affinity RF Tg mice coexpressing the autoantigen. This overproduction was mediated by immune complexes and involved synergistic signaling between the B cell receptor and Toll-like receptors and T cell help. These findings indicate that chronic infection can activate autoreactive B cells with significant affinity and creates conditions that can drive them to differentiate into memory cells. Such cells may have some physiological yet undetermined role, but in autoimmune-prone individuals, this scenario may initiate autoimmunity.

Authors

Pauline Soulas, Anne Woods, Benoit Jaulhac, Anne-Marie Knapp, Jean-Louis Pasquali, Thierry Martin, Anne-Sophie Korganow

×

Figure 5

Options: View larger image (or click on image) Download as PowerPoint
Proliferation and activation of RF B cells in response to B. burgdorferi...
Proliferation and activation of RF B cells in response to B. burgdorferi are increased in the presence of B. burgdorferi/IgG complexes. (A and B) Splenocytes of Hul Tg mice were cultured with suboptimal concentrations (2.5 μg/ml) of sonicated B. burgdorferi, purified human anti–B. burgdorferi huIgG (1 mg/ml), a mixed solution containing B. burgdorferi and purified anti–B. burgdorferi huIgG, or a mixed solution containing B. burgdorferi and nonspecific huIgG (normal huIgG). (A) Side scatter versus forward scatter plots were used to monitor cell size of 17.109high or 17.109low/– B cells (top 2 rows). The next 2 rows of histograms show divisions of CFSE-labeled 17.109high or 17.109low/– B cells; percentages indicate proliferating cells. The bottom row of histograms shows surface expression of CD86 on 17.109high B cells. Thick lines represent the stimulated B cells, and thin lines the nonstimulated B cells. Results shown are representative of 4 separate experiments. Acquisition parameters were determined to analyze at least 2 × 103 cells in the 17.109high or 17.109low/– B cell gates (total numbers of cells: 4 × 104 to 2 × 106). (B) RF supernatant production was measured at day 3. Values ± 1 SEM are shown. *P < 0.05. (C and D) Purified splenic B cells of Hul Tg mice were cultured as in A. (C) CsA (50 ng/ml) was added at culture initiation. Values ± SEM represent the percentage of proliferating IgMa+17.109high cells in the different conditions of stimulation. *P < 0.05. (D) RF supernatant production ± SEM was measured at day 3.

Copyright © 2025 American Society for Clinical Investigation
ISSN: 0021-9738 (print), 1558-8238 (online)

Sign up for email alerts

Referenced in 1 patents
39 readers on Mendeley
1 readers on CiteULike
See more details